| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,402 | +2.68% | |
| 6 months | ₹30,000 | ₹30,671 | +2.24% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 19.29% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 7.93% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 7.91% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 7.83% |
| Max Healthcare Institute Ltd. | Healthcare | Equity | 7.42% |
| Cipla Ltd. | Healthcare | Equity | 7.14% |
| Lupin Ltd. | Healthcare | Equity | 5.82% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 4.57% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 4.29% |
| Laurus Labs Ltd. | Healthcare | Equity | 4.00% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 3.78% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 3.33% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 3.22% |
| Biocon Ltd. | Healthcare | Equity | 2.67% |
| Mankind Pharma Ltd. | Healthcare | Equity | 2.35% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 2.31% |
| Zydus Lifesciences Ltd. | Healthcare | Equity | 2.26% |
| Abbott India Ltd. | Healthcare | Equity | 1.40% |
| Piramal Pharma Ltd. | Healthcare | Equity | 0.88% |
| Syngene International Ltd. | Healthcare | Equity | 0.77% |
| Name | 1M | 3M | 6M | All |
|---|---|---|---|---|
| Fund returns | +2.4% | +4.5% | -1.9% | +3.5% |
| Category average (Equity Sectoral) | -- | -- | -- | -- |
| Rank (Equity Sectoral) | -- | 16 | 13 | -- |